Inovie, Biotech Stock Review

Shorts Set $1.00 Price Target on Inovio (INO) $9.20.

Interesting battle brewing! LIVE CHART Inovio shares tumble 8%...
@NCI

Citius (CTXR) Expands Scientific Advisory Board. Dr. John Laffey, Expert in Stem Cell and...

- Addition of leading scholar and KOL in acute respiratory distress syndrome (ARDS) to ARDS Scientific Advisory Board supports continued progress of...

Todos Medical (TOMDF) Issues Another CoronaVirus Headline, Gains 60%.

Companies With 'CoronaVirus' in Their Press Release Today: Waitr (WTRH) up 86% - Online Food Ordering for Quarantined...
Overstock OSTK,

Video: Famed Shortseller Marc Cohodes Crazy Over Overstock (OSTK).

Two video interviews with Marc Cohodes, formerly with Rocker Partners. Overstock (OSTK), Overstock Preferred (OSTKO), T-ZERO (TZROP)Camping World...

Does Co-Diagnostics (CODX) Have Ties to Offshore Boiler Rooms?

Hot Covid-19 test company has ties to offshore boiler rooms (SharesSleuth.com) AKA, you'd have to have your head examined...
Mitesco, Biotech Stock Review, roland rick perry

Short Squeeze Mania.

Citius Pharma (CTXR) Locked and Loaded. Truly Locked and Loaded. Latest $20 Million Round is Biggest News We've Seen...
Biotech Stock Review, Novellus, Citius

Citius (CTXR) and Stem-Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19

Citius Signs Exclusive Option with Novellus to License Novel Stem-Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19
Dalrada

Adding Dalrada (DFCO) $0.09 to CoronaVirus Stock Watch List.

LIVE QUOTE Adding Dalrada (DFCO), a technology Incubator with interests in telehealth and...

Institutional Analyst Newsletter. April 14, 2022.

Revive Therapeutics (RVVTF) Moves a Step Closer to FDA Verdict LIVE QUOTE

Latest article

Ardelyx (ARDX) Reports First Quarter 2024 Showing $204 Million in Cash!

When we added Ardelyx (ARDX) to the Watch List in November of 2022, the market cap near $80 million. Now it's...

GeoVax to Provide Corporate Update on Tuesday May 14, 2024.

Still our favorite biotech microcap, still our favorite management team, and our favorite risk to reward idea with a $4 million market...

NovaVax (NVAX) Roars Higher, Gaining 225% a $1.2 Billion Increase, at the Blink of...

Sanofi (SNY) Announces Partnership - $500 Million Upfront, plus $700 million in Milestones with NovaVax (NVAX). And some investors say Covid is...